Ted Tentoff
Analyst
Piper Sandler
Equibles does not estimate personal net worth.
About Ted Tentoff
Ted Tentoff is recorded as Analyst at Piper Sandler. Ted Tentoff has spoken on 5 earnings calls across 4 companies, most recently for CytomX Therapeutics, Inc. on November 5, 2026. Those appearances were for Milestone Pharmaceuticals Inc. (MIST), CytomX Therapeutics, Inc. (CTMX), Karyopharm Therapeutics Inc. (KPTI) and Skye Bioscience, Inc. (SKYE). The companies whose calls Ted Tentoff spoke on are classified in the Healthcare sector.
Ted Tentoff on recent calls
“I wanted to ask with respect to the Avastin chemo arm study that you're going to start in which it looks like you're replacing axilla platen. What safety endpoints are you going to be evaluating there to see whether or not the combination with Verceta is better tolerated?”
“And I really appreciated the patient vignettes, Joe. That's really encouraging and cool to hear, because I do think this is a really important therapy.”
“Really an exciting time for CAREF, and you guys just keep on fighting. So I appreciate that. I'm looking forward to the endometrial cancer data coming up. My question is on myelofibrosis.”
“Really, really exciting times for the company. Speaking up on that last question, how long is it taking for reimbursement to kick in? And what is Milestone doing to kind of make sure patients get drug in that delay period?”
Affiliation history
-
Piper Sandler
Analyst
Transcript header (unverified)
Current